Salidroside attenuates lipopolysaccharide (LPS) induced serum cytokines and depressive-like behavior in mice

Neurosci Lett. 2015 Oct 8:606:1-6. doi: 10.1016/j.neulet.2015.08.025. Epub 2015 Aug 20.

Abstract

The aim of the study was to investigate the effects and possible underlying mechanism of salidroside (Sal) on lipopolysaccharide (LPS)-induced depression-like behavior in mice. Sal (12 mg/kg and 24 mg/kg) and fluoxetine (20 mg/kg) were administered intragastrically once daily for 5 days. At the 5th day, LPS (0.5 mg/kg) was injected intraperitoneally 30 min after drug administration. Levels of interleukin (IL)-6 and tumor necrosis factor (TNF)-α in serum were measured by ELISA. Levels of neurotransmitters like norepinephrine (NE) and 5-hydroxytryptamine (5-HT) in the prefrontal cortex were detected by HPLC-MS. Further, brain-derived neurotrophic factor (BDNF), tropomyosin-related kinase B (TrkB) and Nuclear factor-κB (NF-κB) in hippocampal was determined by western blot analysis. Our data showed that pretreatment with Sal dramatically attenuated LPS-induced inflammatory response, decrease of NE and 5-HT levels in the prefrontal cortex. In addition, Sal increased expression levels of BNDF and TrkB. These results suggested that Sal may play a neuroprotective role through the BDNF/TrkB signaling pathway.

Keywords: BDNF; Depression; Inflammation; Lipopolysaccharide; Salidroside.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antidepressive Agents / pharmacology
  • Antidepressive Agents / therapeutic use*
  • Behavior, Animal / drug effects*
  • Brain-Derived Neurotrophic Factor / metabolism
  • Cytokines / blood*
  • Depression / drug therapy*
  • Depression / metabolism
  • Depression / psychology
  • Enzyme Activation
  • Glucosides / pharmacology
  • Glucosides / therapeutic use*
  • Lipopolysaccharides / pharmacology*
  • Male
  • Membrane Glycoproteins / metabolism
  • Mice, Inbred ICR
  • NF-kappa B / metabolism
  • Neuroprotective Agents / pharmacology
  • Neuroprotective Agents / therapeutic use*
  • Norepinephrine / metabolism
  • Phenols / pharmacology
  • Phenols / therapeutic use*
  • Protein-Tyrosine Kinases / metabolism
  • Serotonin / metabolism

Substances

  • Antidepressive Agents
  • Brain-Derived Neurotrophic Factor
  • Cytokines
  • Glucosides
  • Lipopolysaccharides
  • Membrane Glycoproteins
  • NF-kappa B
  • Neuroprotective Agents
  • Phenols
  • Serotonin
  • Ntrk2 protein, mouse
  • Protein-Tyrosine Kinases
  • rhodioloside
  • Norepinephrine